Privia Health Group, Inc.
NASDAQ:PRVAMedical - Healthcare Information Services
+$0.15 today
- Market cap
- $3.14B
- Beta
- 0.87
- P/E (TTM)
- 134.4
- EPS (TTM)
- $0.18
Volume 2.38M
Average 0.95M
PRVA Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Privia Health Group, Inc.NASDAQ: PRVA
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity rises 14.2% from a year ago
Total equity stood at $838.07M at the end of Q2 FY2026, up 14.2% from a year earlier and up 4.0% from the prior quarter. Over 3 fiscal years it compounded at +15.1% a year.
Context
- Total equity amounted to 56.3% of total assets at the end of Q2 FY2026, down 1.3 pp from a year earlier.
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +14.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 790.94M USD
- Year-over-year change
- +15.7%
- 4-year CAGR
- +15.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 790.94M | +15.7% |
| FY2024 | 2024-12-31 | 683.45M | +12.5% |
| FY2023 | 2023-12-31 | 607.39M | +17.0% |
| FY2022 | 2022-12-31 | 519.05M | +15.3% |
| FY2021 | 2021-12-31 | 450.18M | — |
Total Equity vs competitors
How PRVA compares with its peers on the latest reported figures
- PRVA's Jun 2026 total equity of $838.07M is the 2nd highest of the 10 companies compared; the peer median is $240.12M.
- Its year-over-year change of +14.2% is the 3rd highest of 10, against a peer median of -6.4%.
- Total equity amounts to 56.3% of total assets for PRVA, versus a peer median of 47.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.34B | -6.4% | -15.6% | 47.6% | |
| Jun 2026 | $838.07M | +14.2% | +15.1% | 56.3% | |
| Mar 2026 | $577.46M | +11.5% | -0.0% | 24.5% | |
| Mar 2026 | $396.39M | -57.6% | -21.5% | 21.1% | |
| Apr 2026 | $359.09M | +27.3% | +5.4% | 53.9% | |
| Mar 2026 | $240.12M | -21.5% | -38.9% | 73.7% | |
| Mar 2026 | $234.12M | +296.9% | +13.9% | 77.3% | |
| Mar 2026 | $181.43M | -63.7% | -50.4% | 12.1% | |
| Mar 2026 | $138.15M | -63.3% | -16.7% | 33.5% | |
| Mar 2026 | $58.33M | +7.7% | -16.4% | 67.3% | |
| Peer median (excluding PRVA) | $240.12M | -6.4% | -16.4% | 47.6% | |
Competitors are the stored peer set for PRVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 320.58M | 347.99M | 389.51M | 491.15M | 479.69M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 117.4M | 189.6M | 290.77M | 316.18M | 400.9M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 14.37M | 20.53M | 27.5M | 30.41M |
| Total Current Assets | 446.68M | 551.96M | 700.8M | 834.82M | 911M |
| Property, Plant & Equipment (Net) | 14.14M | 11.48M | 8.94M | 6.07M | 9.3M |
| Goodwill | 127.94M | 126.94M | 138.75M | 141.62M | 209.84M |
| Intangible Assets | 59.74M | 57.39M | 107.63M | 109.81M | 215.92M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 33.36M | 40.37M | 35.2M | 26.38M | 2.27M |
| Other Non-current Assets | 4.52M | 4.68M | 8.58M | 17.09M | 21.04M |
| Total Non-current Assets | 239.7M | 240.85M | 299.1M | 300.96M | 458.38M |
| Total Assets | 686.37M | 792.81M | 999.9M | 1.14B | 1.37B |
| Account Payables | 2.97M | 6.73M | 7.88M | 9.76M | 7.97M |
| Short-term Debt | 875K | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 148.2M | 214.6M | 332.05M | 370.61M | 503.07M |
| Total Current Liabilities | 190.46M | 264.27M | 386.95M | 449.15M | 568.52M |
| Long-term Debt | 31.69M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3M | 1M | 313K | 153K | 2.58M |
| Total Non-current Liabilities | 45.73M | 9.49M | 5.56M | 3.19M | 9.92M |
| Total Liabilities | 236.19M | 273.76M | 392.51M | 452.34M | 578.44M |
| Common Stock | 1.08M | 1.15M | 1.18M | 1.2M | 1.24M |
| Retained Earnings | (208.11M) | (216.69M) | (193.61M) | (179.23M) | (156.31M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 23.31M | 19.96M | 45.95M | 48.26M | 53.73M |
| Total Equity | 450.18M | 519.05M | 607.39M | 683.45M | 790.94M |
| Total Debt | 46.5M | 11.5M | 8.29M | 5.59M | 9.53M |
| Net Debt | (274.08M) | (336.49M) | (381.22M) | (485.56M) | (470.15M) |
Privia Health Group, Inc.
NASDAQ:PRVA
Intrinsic Alpha fair value
Locked
Current Price
$24.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.